Lobbying ≠ campaign money. These LDA lobbying figures are a separate, unbridged channel from FEC campaign contributions; this platform does not yet link a lobbying registrant to any FEC committee. See the methodology glossary.
AMGEN, INC.
Lobbying registrant · 3867
2 filings on record; a reported $5,020,000 in total across them. Honesty note: each amount is the registrant's reported lobbying income/spend for that quarter (a lump sum required by the Lobbying Disclosure Act, or LDA — the law governing public lobbying reports), so this total is a gross sum of quarterly figures. The filings do disclose which bills were lobbied on (below), but never how much of the money went to any one bill, and never whether the filer supported or opposed it.
Clients
Filings
| Client | Period | Reported quarterly amount | Filing type |
|---|---|---|---|
| AMGEN INC | Q2 2026 | $2,440,000 | Q2 |
| AMGEN INC | Q1 2026 | $2,580,000 | Q1 |
Source: Senate LDA filings.
Bills lobbied on
Bills named in this registrant's filings. A titled link means the bill is in our corpus; a bare canonical reference means it is not.
- A concurrent resolution establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. (us-119-hconres-14)
- An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. (us-119-hr-1)
- us-119-hr-1492 (not in corpus)
- us-119-hr-1574 (not in corpus)
- us-119-hr-1672 (not in corpus)
- us-119-hr-3152 (not in corpus)
- us-119-hr-3160 (not in corpus)
- us-119-hr-3269 (not in corpus)
- Protecting Patient Access to Cancer and Complex Therapies Act (us-119-hr-4299)
- us-119-hr-4317 (not in corpus)
- us-119-hr-5256 (not in corpus)
- Biosimilar Red Tape Elimination Act (us-119-hr-5526)
- Lowering Drug Costs for American Families Act (us-119-hr-6166)
- us-119-hr-6485 (not in corpus)
- us-119-hr-6624 (not in corpus)
- us-119-hr-7391 (not in corpus)
- us-119-hr-7837 (not in corpus)
- us-119-hr-8143 (not in corpus)
- Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (us-119-hr-8646)
- National Defense Authorization Act for Fiscal Year 2027 (us-119-hr-8800)
- us-119-hr-9102 (not in corpus)
- us-119-s-1040 (not in corpus)
- Affordable Prescriptions for Patients Act (us-119-s-1041)
- Expedited Access to Biosimilars Act (us-119-s-1414)
- us-119-s-1546 (not in corpus)
- us-119-s-1553 (not in corpus)
- Biosimilar Red Tape Elimination Act (us-119-s-1954)
- Secure America Act (us-119-s-2)
- us-119-s-2276 (not in corpus)
- Patients Deserve Price Tags Act (us-119-s-2355)
- us-119-s-2658 (not in corpus)
- us-119-s-3014 (not in corpus)
- us-119-s-3019 (not in corpus)
- us-119-s-3345 (not in corpus)
- us-119-s-3349 (not in corpus)
- us-119-s-3452 (not in corpus)
- us-119-s-3510 (not in corpus)
- CLEAR LABELS Act (us-119-s-3788)
- us-119-s-43 (not in corpus)
- us-119-s-4323 (not in corpus)
- us-119-s-708 (not in corpus)
Bill references are free-text extractions from LDA specific_issues;
they show a bill was named in a quarter, not money spent on it.